250 related articles for article (PubMed ID: 34990024)
1. Drug-Drug Interactions in People Living With HIV at Risk of Hepatic and Renal Impairment: Current Status and Future Perspectives.
Cottura N; Kinvig H; Grañana-Castillo S; Wood A; Siccardi M
J Clin Pharmacol; 2022 Jul; 62(7):835-846. PubMed ID: 34990024
[TBL] [Abstract][Full Text] [Related]
2. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications.
Priyanka PSSL; Varma DM; Immadisetti K; Rajesh R; Vidyasagar S; Guddattu V
Int J Risk Saf Med; 2017; 29(1-2):25-55. PubMed ID: 28885219
[TBL] [Abstract][Full Text] [Related]
3. The intersection of drug interactions and adverse reactions in contemporary antiretroviral therapy.
Nhean S; Tseng A; Back D
Curr Opin HIV AIDS; 2021 Nov; 16(6):292-302. PubMed ID: 34459470
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and management of drug-drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study.
Schlaeppi C; Vanobberghen F; Sikalengo G; Glass TR; Ndege RC; Foe G; Kuemmerle A; Paris DH; Battegay M; Marzolini C; Weisser M;
HIV Med; 2020 Jan; 21(1):53-63. PubMed ID: 31532898
[TBL] [Abstract][Full Text] [Related]
5. Use of comedications and potential drug-drug interactions in people living with HIV in China.
Chen R; Chen J; Tang Q; Meng Z; Luo L; Zhang W; Deng A; Zhang L; Wang J; Qi T; Zhang R; Shen Y; Liu L; Steinhart C; Lu H
J Infect Chemother; 2020 Jul; 26(7):722-728. PubMed ID: 32354599
[TBL] [Abstract][Full Text] [Related]
6. The Challenge of Potential Drug-Drug Interactions Among People Living With HIV on Antiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China.
Xia H; Gao L; Gong X; Zaongo SD; Zhang T; Wu H; Ma P; Huang X
Front Pharmacol; 2020; 11():800. PubMed ID: 32536872
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of drug-drug interactions of antiretroviral agents in the private health care sector in South Africa.
Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
S Afr Med J; 2008 Feb; 98(2):109-13. PubMed ID: 18350204
[TBL] [Abstract][Full Text] [Related]
8. Comedication prescription patterns and potential for drug-drug interactions with antiretroviral therapy in people living with human immunodeficiency virus type 1 infection in Germany.
Lopes S; O'Day K; Meyer K; Van Stiphout J; Punekar Y; Radford M; Haas JS
Pharmacoepidemiol Drug Saf; 2020 Mar; 29(3):270-278. PubMed ID: 31950545
[TBL] [Abstract][Full Text] [Related]
9. Polypharmacy and potential drug-drug interactions among people living with HIV in the era of integrase strand transfer inhibitor-based antiretroviral therapy.
Peng AT; Huang SH; Lee HY; Wu PY; Kuo HY; Hung CC
Int J Antimicrob Agents; 2024 Feb; 63(2):107067. PubMed ID: 38141835
[TBL] [Abstract][Full Text] [Related]
10. Polypharmacy and potential drug-drug interactions for people with HIV in the UK from the Climate-HIV database.
Okoli C; Schwenk A; Radford M; Myland M; Taylor S; Darley A; Barnes J; Fox A; Grimson F; Reeves I; Munshi S; Croucher A; Boxall N; Benn P; Paice A; van Wyk J; Khoo S
HIV Med; 2020 Sep; 21(8):471-480. PubMed ID: 32671950
[TBL] [Abstract][Full Text] [Related]
11. Drug interactions and the role of pharmacokinetic trials in guiding choices in first-line HIV therapy in low-income and middle-income countries.
Seden K; Boffito M; Khoo S
Curr Opin HIV AIDS; 2017 Jul; 12(4):377-382. PubMed ID: 28570369
[TBL] [Abstract][Full Text] [Related]
12. Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs.
Fuster-RuizdeApodaca MJ; Castro-Granell V; Laguía A; Jaén Á; Cenoz S; Galindo MJ
AIDS Res Ther; 2020 May; 17(1):24. PubMed ID: 32448214
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of drug-drug interactions in the era of HIV integrase inhibitors: a retrospective clinical study.
Baecke C; Gyssens IC; Decoutere L; van der Hilst JCH; Messiaen P
Neth J Med; 2017 Jul; 75(6):235-240. PubMed ID: 28741582
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and type of drug-drug interactions involving ART in patients attending a specialist HIV outpatient clinic in Kampala, Uganda.
Seden K; Merry C; Hewson R; Siccardi M; Lamorde M; Byakika-Kibwika P; Laker E; Parkes-Ratanshi R; Back DJ; Khoo SH
J Antimicrob Chemother; 2015 Dec; 70(12):3317-22. PubMed ID: 26286575
[TBL] [Abstract][Full Text] [Related]
15. Managing Pharmacotherapy in People Living With HIV and Concomitant Malignancy.
Olin JL; Klibanov O; Chan A; Spooner LM
Ann Pharmacother; 2019 Aug; 53(8):812-832. PubMed ID: 30770025
[No Abstract] [Full Text] [Related]
16. Co-medications and Drug-Drug Interactions in People Living with HIV in Turkey in the Era of Integrase Inhibitors.
Yeşilbağ Z; Şengül Eİ; Şenoğlu S; Aydın ÖA; Karaosmanoğlu HK
Curr HIV Res; 2020; 18(6):415-425. PubMed ID: 32787762
[TBL] [Abstract][Full Text] [Related]
17. Recognition and management of clinically significant drug-drug interactions between antiretrovirals and co-medications in a cohort of people living with HIV in rural Tanzania: a prospective questionnaire-based study.
Kuemmerle A; Sikalengo G; Vanobberghen F; Ndege RC; Foe G; Schlaeppi C; Burri C; Battegay M; Paris DH; Glass TR; Weisser M; Marzolini C;
J Antimicrob Chemother; 2021 Sep; 76(10):2681-2689. PubMed ID: 34337653
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable.
Seden K; Back D; Khoo S
J Antimicrob Chemother; 2009 Jul; 64(1):5-8. PubMed ID: 19398457
[TBL] [Abstract][Full Text] [Related]
19. High frequency of potential phosphodiesterase type 5 inhibitor drug interactions in males with HIV infection and erectile dysfunction.
Cota JM; Benavides TM; Fields JD; Jansen N; Ganesan A; Colombo RE; Blaylock JM; Maves RC; Agan BK; Okulicz JF
PLoS One; 2021; 16(5):e0250607. PubMed ID: 33956843
[TBL] [Abstract][Full Text] [Related]
20. Polypharmacy and Drug-Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based Study.
López-Centeno B; Badenes-Olmedo C; Mataix-Sanjuan Á; McAllister K; Bellón JM; Gibbons S; Balsalobre P; Pérez-Latorre L; Benedí J; Marzolini C; Aranguren-Oyarzábal A; Khoo S; Calvo-Alcántara MJ; Berenguer J
Clin Infect Dis; 2020 Jul; 71(2):353-362. PubMed ID: 31428770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]